Sls Stock Analysis Sellas Life Sciences Group Inc. Gains 1.06 Pct Trades At 4.28 Level 20260401 1 Artesian Resources Corporation ARTNA Q3 2025 Earnings Marginal EPS Beat Amid Steady Utility Operations BTU Q1 2026 Earnings Significant EPS Miss Amid Challenging Coal Market Conditions 374Water Inc SCWO Q1 2026 Earnings Net Loss Widens as Development Continues Without Revenue Surrozen Inc SRZN Q1 2026 Earnings Significant EPS Miss Reflects Ongoing ClinicalStage Spending No Revenue Reported Genprex GNPX Q1 2026 Earnings Continued RD Investment as Gene Therapy Pipeline Progresses OCGN Q1 2026 Earnings WiderthanExpected Loss as Preclinical Pipeline Progress Continues